Evidence map›Paper›PMID 39845121›Full record

ArticleRSC advances2025

An electroanalytical sensor for the detection of antibiotic cefoperazone sodium sulbactam sodium residue in wastewater.

Mohsin Javed, Afzal Shah, Muhammad Umar Farooq

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohsin JavedDepartment of Chemistry, Quaid-i-Azam University Islamabad 45320 Pakistan afzals_qau@yahoo.com.
Afzal ShahDepartment of Chemistry, Quaid-i-Azam University Islamabad 45320 Pakistan afzals_qau@yahoo.com.ORCID https://orcid.org/0000-0002-9465-9185
Muhammad Umar FarooqNational Center for Physics Islamabad 45320 Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The misuse and uncontrolled release of pharmaceuticals into water bodies lead to environmental challenges and the development of resistance, thereby reducing their effectiveness. To mitigate these problems, it is essential to identify pharmaceuticals in water sources and eliminate them prior to human use. This study presents the designing of a novel nanosensor for the detection of the antibiotic Cefoperazone Sodium Sulbactam Sodium (CSSS). The nanosensor was prepared by modifying the surface of a glassy carbon electrode (GCE) with the nanoparticles of NiO and MWCNTs. A green synthetic method was applied for the synthesis of NiO nanoparticles. Their structural and morphological characterization was conducted using X-ray diffraction and scanning electron microscopy, while optical properties were assessed through UV-vis spectroscopy. NiO nanoparticles in conjunction with MWCNTs enhanced the sensitivity of the GCE for the detection of CSSS. Electrochemical impedance spectroscopy revealed efficient charge transport through the designed sensing platform designated as NiO/MWCNTs/GCE. Square wave voltammetry demonstrated an eightfold increase in peak current intensity of CSSS at the NiO/MWCNTs/GCE as compared to the unmodified GCE. The electrochemical analysis of CSSS in solution of different pH indicated the involvement of protons during electron transfer reactions of CSSS. The limit of detection of CSSS with a value of 3.31 nM was obtained at the designed sensing platform under optimized experimental conditions. The current investigations combine advanced materials with principles of green chemistry, significantly enhancing efforts in wastewater remediation from antibiotic drugs.

Identifiers

PMID39845121
PMCPMC11751673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.